Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2

Journal of Experimental Medicine

Volumn 192, Issue 9, 2000, Pages 1339-1351

  Chen, Zhibin ^a   Koralov, Sergei B ^a   Kelsoe, Garnett ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoantibody; Complement; Glomerulonephritis; Immune complex; Splenomegaly

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; HUMORAL IMMUNE DEFICIENCY; IMMUNE COMPLEX DEPOSITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNITY; CELLS, CULTURED; COMPLEMENT C4; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DELETION; HISTOCYTOCHEMISTRY; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; SPLEEN; SPLENOMEGALY;

EID: 0034613725     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.9.1339     Document Type: Article

References (69)

1. Systemic lupus erythematosus
2. Systemic lupus erythematosus
3. Autoreactive T cells in murine lupus: Origins and roles in autoantibody production
4. Genetic dissection of systemic lupus erythematosus
5. Genetic susceptibility to systemic lupus erythematosus
6. Infectious diseases associated with complement deficiencies
7. Complement deficiency states and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
8. Complement deficiency and autoimmunity
9. Inherited deficiency of the fourth component of human complement
10. Serum levels of C1q, C1r and C1s in normal and pathologic sera
11. Complement components, C1 activation and disease activity in SLE
12. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus
13. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
14. The classical complement pathway: Activation and regulation of the first complement component
15. The complement components coded in the major histocompatibllity complexes and their biological activities
16. The role of complement and complement receptors in induction and regulation of immunity
17. Complement defense mechanisms
18. C1q and systemic lupus erythematosus
19. Receptors for complement of leukocytes
20. Role of complement in induction of the allergic response
21. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
22. Regulation of the B cell response to T-dependent antigens by classical pathway complement
23. T cell-dependent immune response in C1q-deficient mice: Defective interferon gamma production by antigen-specific T cells
24. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
25. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
26. Humoral immune responses in Cr2(-/-) mice: Enhanced affinity maturation but impaired antibody persistence
27. The follicular dendritic cell: Its role in antigen presentation in the generation of immunological memory
28. The central role of follicular dendritic cells in lymphoid tissues
29. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells
30. Dual antigen recognition by B cells
31. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity
32. A critical role for complement in maintenance of self-tolerance
33. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus
34. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): Expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
35. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies
36. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation
37. Problems in ANA test interpretation: A comparison of two substrates
38. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique
39. Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development
40. Lack of allelic exclusion permits autoreactive B cells to escape deletion
41. Light chain usage in anti-double-stranded DNA B cell subsets: Role in cell fate determination
42. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition
43. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations
44. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis
45. Genetic dissection of lupus pathogenesis: A recipe for nephrophilic autoantibodies
46. Flow cytometric identification of murine neutrophils and monocytes
47. Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells
48. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells
49. The role of somatic mutation in the pathogenic anti-DNA response
50. The lupus paradox
51. Inherited complement component abnormalities
52. The molecular genetics of components of complement
53. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells In vivo
54. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
55. Complement-dependent clearance of apoptotic cells by human macrophages
56. Systemic exposure to irradiated apoptotic cells induces autoantibody production
57. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
58. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
59. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus
60. NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases
61. Mechanisms of phagocytosis in macrophages
62. In vivo studies in C4-deficient guinea pigs
63. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease
64. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion
65. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CK1) and Crry, the two genetic homologues of human CR1
66. Characterization of C3-binding proteins on mouse neutrophils and platelets
67. Complement receptors and phagocytosis
68. C1q-binding proteins and C1q receptors
69. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro